• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫吸附剂治疗系统性红斑狼疮的临床试验。

Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy.

作者信息

Gao C L, Li B A, Chen C Z, Yu Y T, Yuan P, Song J C

机构信息

Institute for Molecular Biology, Nankai University, Tianjin, China.

出版信息

Artif Organs. 1995 May;19(5):468-9. doi: 10.1111/j.1525-1594.1995.tb02360.x.

DOI:10.1111/j.1525-1594.1995.tb02360.x
PMID:7625928
Abstract

Five patients with systemic lupus erythematosus (SLE) were perfused through an extracorporeal shunt filled with DNA-immunoadsorbent (DNA immobilized on carbonized resin beads). High concentrations of anti-DNA antibodies (36.4-67.0%) (binding percentage with 125I-DNA) in the serum of SLE patients were reduced to 13.8-53.0%, respectively. The highest removal percentage was 62.1%. Although the decline levels varied, the symptoms of patients, i.e., long-term severe joint pain, severe edema, hydropericardium, and ascites were all relieved considerably. The immunoadsorbent showed satisfactory blood compatibility.

摘要

五名系统性红斑狼疮(SLE)患者通过充满DNA免疫吸附剂(固定在碳化树脂珠上的DNA)的体外分流器进行灌注。SLE患者血清中高浓度的抗DNA抗体(36.4 - 67.0%)(与125I - DNA的结合百分比)分别降至13.8 - 53.0%。最高清除率为62.1%。尽管下降水平有所不同,但患者的症状,即长期严重关节疼痛、严重水肿、心包积液和腹水均得到了显著缓解。该免疫吸附剂显示出令人满意的血液相容性。

相似文献

1
Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy.免疫吸附剂治疗系统性红斑狼疮的临床试验。
Artif Organs. 1995 May;19(5):468-9. doi: 10.1111/j.1525-1594.1995.tb02360.x.
2
Clinical trials of type I and in vitro studies of type II immunoadsorbents for systemic lupus erythematosus therapy.用于系统性红斑狼疮治疗的I型免疫吸附剂的临床试验及II型免疫吸附剂的体外研究。
Artif Organs. 1998 Aug;22(8):644-50. doi: 10.1046/j.1525-1594.1998.06010.x.
3
[Efficacy of immunosorption in patients with systemic lupus erythematosus: double blind controlled trial].
Ter Arkh. 1997;69(12):18-22.
4
A new DNA immune adsorbent for hemoperfusion in SLE therapy: a clinical trial.
Artif Organs. 1988 Oct;12(5):444-6. doi: 10.1111/j.1525-1594.1988.tb02799.x.
5
Immunoadsorbent (IM-P) plasma perfusion in patients with rheumatoid arthritis or SLE.类风湿关节炎或系统性红斑狼疮患者的免疫吸附(IM-P)血浆灌注
Life Support Syst. 1983;1 Suppl 1:98-101.
6
Preparation of DNA-immobilized immunoadsorbent for treatment of systemic lupus erythematosus.用于治疗系统性红斑狼疮的DNA固定化免疫吸附剂的制备
J Biomater Sci Polym Ed. 1999;10(3):341-50. doi: 10.1163/156856299x00405.
7
Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.系统性红斑狼疮患者的免疫吸附血浆灌注
J Rheumatol. 1990 Jul;17(7):900-7.
8
Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis.利用 DNA 固定化纳米纤维素免疫吸附剂进行系统性红斑狼疮血浆置换的可行性。
Colloids Surf B Biointerfaces. 2016 Jul 1;143:1-6. doi: 10.1016/j.colsurfb.2016.03.014. Epub 2016 Mar 7.
9
Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
J Autoimmun. 1998 Oct;11(5):495-501. doi: 10.1006/jaut.1998.0229.
10
Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus.使用硫酸葡聚糖纤维素柱(Selesorb)治疗性选择性吸附抗DNA抗体治疗系统性红斑狼疮。
Ther Apher. 1998 Feb;2(1):18-24. doi: 10.1111/j.1744-9987.1998.tb00068.x.